Rakovina Therapeutics Inc (RKV) — Working Capital to Net Assets Ratio

Rakovina Therapeutics Inc (RKV) has a Working Capital to Net Assets ratio of -25.9% as of September 2025. Working capital of CA$-489.28K (current assets of CA$1.69 Million minus current liabilities of CA$2.18 Million) is measured against net assets of CA$1.89 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See defensive interval ratio of Rakovina Therapeutics Inc to measure how many days the company can operate on defensive assets alone.